Marizyme MRZM Stock
Marizyme Price Chart
Marizyme MRZM Financial and Trading Overview
| Marizyme stock price | 0.06 USD |
| Previous Close | 0.23 USD |
| Open | 0.28 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.23 - 0.23 USD |
| 52 Week Range | 0.07 - 3.25 USD |
| Volume | 982 USD |
| Avg. Volume | 6.33K USD |
| Market Cap | 2.5M USD |
| Beta (5Y Monthly) | 0.60176 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.86 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MRZM Valuation Measures
| Enterprise Value | 17.48M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.888153 |
| Price/Book (mrq) | 0.61497325 |
| Enterprise Value/Revenue | 48.22 |
| Enterprise Value/EBITDA | -1.702 |
Trading Information
Marizyme Stock Price History
| Beta (5Y Monthly) | 0.60176 |
| 52-Week Change | -90.79% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.25 USD |
| 52 Week Low | 0.07 USD |
| 50-Day Moving Average | 0.15 USD |
| 200-Day Moving Average | 0.89 USD |
MRZM Share Statistics
| Avg. Volume (3 month) | 6.33K USD |
| Avg. Daily Volume (10-Days) | 8.28K USD |
| Shares Outstanding | 10.86M |
| Float | 25.82M |
| Short Ratio | N/A |
| % Held by Insiders | 2.03% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3065.54% |
| Gross Margin | 64.19% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -13.44% |
| Return on Equity (ttm) | -114.39% |
Income Statement
| Revenue (ttm) | 362.46K USD |
| Revenue Per Share (ttm) | 0.009 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -10269917 USD |
| Net Income Avi to Common (ttm) | -34595568 USD |
| Diluted EPS (ttm) | -1.1 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 329.81K USD |
| Total Cash Per Share (mrq) | 0.008 USD |
| Total Debt (mrq) | 7.82M USD |
| Total Debt/Equity (mrq) | 51.35 USD |
| Current Ratio (mrq) | 0.234 |
| Book Value Per Share (mrq) | 0.374 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7658560 USD |
| Levered Free Cash Flow (ttm) | -6124731 USD |
Profile of Marizyme
| Country | United States |
| State | FL |
| City | Jupiter |
| Address | 555 Heritage Drive |
| ZIP | 33458 |
| Phone | (561) 935-9955 |
| Website | https://www.marizyme.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 13 |
Marizyme, Inc., a multi-technology biomedical company, engages in the development and commercialization of medical technologies business. It offers DuraGraft, a one-time intraoperative vascular graft treatment for use in vascular and bypass surgeries that maintains endothelial function and structure, and other related properties. The company also develops various products using its Krillase protease-based therapeutic platform for treating chronic wounds and burns, thrombosis, and dissolving plaque and biofilms on teeth. In addition, it focuses on developing products to mitigate the effects of ischemia reperfusion injury in other grafting and transplantation surgeries, and other indications. Further, it is involved in developing MATLOC, a point-of-care, lab-on-chip digital screening and diagnostic device platform for chronic kidney disease assessment; and MAR-FG-001, a fat grafting technology for use in fat grafting procedures. The company was formerly known as GBS Enterprises Incorporated and changed its name to Marizyme, Inc. in March 2018. Marizyme, Inc. was incorporated in 2007 and is based in Jupiter, Florida.
Q&A For Marizyme Stock
What is a current MRZM stock price?
Marizyme MRZM stock price today per share is 0.06 USD.
How to purchase Marizyme stock?
You can buy MRZM shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Marizyme?
The stock symbol or ticker of Marizyme is MRZM.
Which industry does the Marizyme company belong to?
The Marizyme industry is Biotechnology.
How many shares does Marizyme have in circulation?
The max supply of Marizyme shares is 46.67M.
What is Marizyme Price to Earnings Ratio (PE Ratio)?
Marizyme PE Ratio is now.
What was Marizyme earnings per share over the trailing 12 months (TTM)?
Marizyme EPS is -1.86 USD over the trailing 12 months.
Which sector does the Marizyme company belong to?
The Marizyme sector is Healthcare.